{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:56:45Z","timestamp":1784289405866,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing-Tianjin-Hebei Basic Research Project of Tianjin Science and Technology Bureau","award":["22JCZXJC00040"],"award-info":[{"award-number":["22JCZXJC00040"]}]},{"name":"Public Health Science and Technology Major Project of the Tianjin Science and Technology Bureau","award":["21ZxGWSY00020"],"award-info":[{"award-number":["21ZxGWSY00020"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-010A"],"award-info":[{"award-number":["TJYXZDXK-010A"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-009A"],"award-info":[{"award-number":["TJYXZDXK-009A"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172821"],"award-info":[{"award-number":["82172821"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019065","name":"Tianjin Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["19JCYBJC27400"],"award-info":[{"award-number":["19JCYBJC27400"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Science and Technology Development Fund of Tianjin Education Commission for Higher Education","award":["2021ZD033"],"award-info":[{"award-number":["2021ZD033"]}]},{"name":"Tianjin Health Research Project","award":["TJWJ2022XK024"],"award-info":[{"award-number":["TJWJ2022XK024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Proced Online"],"DOI":"10.1186\/s12575-025-00288-z","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T08:54:27Z","timestamp":1753520067000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive Insights into APOBEC Mutations in Thyroid Cancer: Prognostic and Therapeutic Discoveries"],"prefix":"10.1186","volume":"27","author":[{"given":"Wei","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhui","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"issue":"5","key":"288_CR1","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","volume":"171","author":"I Martincorena","year":"2017","unstructured":"Martincorena I, et al. Universal Patterns of Selection in Cancer and Somatic Tissues. Cell. 2017;171(5):1029\u2013e104121.","journal-title":"Cell"},{"issue":"6255","key":"288_CR2","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1126\/science.aab4082","volume":"349","author":"I Martincorena","year":"2015","unstructured":"Martincorena I, Campbell PJ. Somatic Mutation in Cancer and Normal Cells. Science. 2015;349(6255):1483\u20139.","journal-title":"Science"},{"issue":"6591","key":"288_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1126\/science.abo7425","volume":"376","author":"D Sz\u00fcts","year":"2022","unstructured":"Sz\u00fcts D. A Fresh Look At Somatic Mutations in Cancer. Science. 2022;376(6591):351\u20132.","journal-title":"Science"},{"issue":"6","key":"288_CR4","first-page":"1085","volume":"19","author":"IB Rogozin","year":"2018","unstructured":"Rogozin IB, et al. Mutational Signatures and Mutable Motifs in Cancer Genomes. Brief Bioinform. 2018;19(6):1085\u2013101.","journal-title":"Brief Bioinform"},{"issue":"7463","key":"288_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, et al. Signatures of Mutational Processes in Human Cancer. Nature. 2013;500(7463):415\u201321.","journal-title":"Nature"},{"issue":"6331","key":"288_CR6","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1126\/science.aaf9011","volume":"355","author":"C Tomasetti","year":"2017","unstructured":"Tomasetti C, Li L, Vogelstein B. Stem Cell Divisions, Somatic Mutations, Cancer Etiology, and Cancer Prevention. Science. 2017;355(6331):1330\u20134.","journal-title":"Science"},{"issue":"11","key":"288_CR7","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/s41588-020-00727-5","volume":"52","author":"A Balmain","year":"2020","unstructured":"Balmain A. The Critical Roles of Somatic Mutations and Environmental Tumor-promoting Agents in Cancer Risk. Nat Genet. 2020;52(11):1139\u201343.","journal-title":"Nat Genet"},{"issue":"20","key":"288_CR8","doi-asserted-by":"publisher","first-page":"7354","DOI":"10.1039\/D0CS00647E","volume":"49","author":"C Mingard","year":"2020","unstructured":"Mingard C, et al. Next-generation DNA Damage Sequencing. Chem Soc Rev. 2020;49(20):7354\u201377.","journal-title":"Chem Soc Rev"},{"issue":"5","key":"288_CR9","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.cell.2017.09.048","volume":"171","author":"BB Campbell","year":"2017","unstructured":"Campbell BB, et al. Comprehensive analysis of hypermutation in human Cancer. Cell. 2017;171(5):1042\u2013e105610.","journal-title":"Cell"},{"issue":"8017","key":"288_CR10","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41586-024-07490-1","volume":"630","author":"CJ Anderson","year":"2024","unstructured":"Anderson CJ, et al. Strand-resolved Mutagenicity of DNA Damage and Repair. Nature. 2024;630(8017):744\u201351.","journal-title":"Nature"},{"issue":"6705","key":"288_CR11","doi-asserted-by":"publisher","first-page":"eadl6173","DOI":"10.1126\/science.adl6173","volume":"385","author":"MJ Wu","year":"2024","unstructured":"Wu MJ, et al. Mutant IDH1 Inhibition Induces DsDNA Sensing to Activate Tumor Immunity. Science. 2024;385(6705):eadl6173.","journal-title":"Science"},{"issue":"10","key":"288_CR12","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.ccell.2023.09.006","volume":"41","author":"M Zhu","year":"2023","unstructured":"Zhu M, et al. Loss of p53 and Mutational Heterogeneity Drives Immune Resistance in an Autochthonous Mouse Lung Cancer Model With High Tumor Mutational Burden. Cancer Cell. 2023;41(10):1731\u2013e17488.","journal-title":"Cancer Cell"},{"issue":"1","key":"288_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/annonc\/mdu479","volume":"26","author":"F Favero","year":"2015","unstructured":"Favero F, et al. Sequenza: Allele-specific Copy Number and Mutation Profiles From Tumor Sequencing Data. Ann Oncol. 2015;26(1):64\u201370.","journal-title":"Ann Oncol"},{"issue":"2","key":"288_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1053\/j.gastro.2024.02.046","volume":"167","author":"Y Xie","year":"2024","unstructured":"Xie Y, et al. Targeting ESE3\/EHF With Nifurtimox Inhibits CXCR2(+) Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and Immunotherapy. Gastroenterology. 2024;167(2):281\u201397.","journal-title":"Gastroenterology"},{"issue":"21","key":"288_CR15","doi-asserted-by":"publisher","first-page":"7759","DOI":"10.1073\/pnas.1403361111","volume":"111","author":"K Halemano","year":"2014","unstructured":"Halemano K, et al. Immunoglobulin Somatic Hypermutation By APOBEC3\/Rfv3 During Retroviral Infection. Proc Natl Acad Sci U S A. 2014;111(21):7759\u201364.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7897","key":"288_CR16","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41586-022-04398-6","volume":"602","author":"EN Bergstrom","year":"2022","unstructured":"Bergstrom EN, et al. Mapping Clustered Mutations in Cancer Reveals APOBEC3 Mutagenesis of EcDNA. Nature. 2022;602(7897):510\u20137.","journal-title":"Nature"},{"issue":"6","key":"288_CR17","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cell.2019.02.012","volume":"176","author":"M Petljak","year":"2019","unstructured":"Petljak M, et al. Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis. Cell. 2019;176(6):1282\u2013e129420.","journal-title":"Cell"},{"issue":"7","key":"288_CR18","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.tibs.2016.05.001","volume":"41","author":"JD Salter","year":"2016","unstructured":"Salter JD, Bennett RP, Smith HC. The APOBEC Protein Family: United By Structure, Divergent in Function. Trends Biochem Sci. 2016;41(7):578\u201394.","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"288_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.tibs.2007.01.004","volume":"32","author":"RK Holmes","year":"2007","unstructured":"Holmes RK, Malim MH, Bishop KN. APOBEC-mediated Viral Restriction: Not Simply Editing? Trends Biochem Sci. 2007;32(3):118\u201328.","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"288_CR20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/annonc\/mdy003","volume":"29","author":"S Venkatesan","year":"2018","unstructured":"Venkatesan S, et al. Perspective: APOBEC Mutagenesis in Drug Resistance and Immune Escape in HIV and Cancer Evolution. Ann Oncol. 2018;29(3):563\u201372.","journal-title":"Ann Oncol"},{"key":"288_CR21","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.2147\/IDR.S484265","volume":"17","author":"X Yang","year":"2024","unstructured":"Yang X, Wang H, Yu C. The Mechanism of APOBEC3B in Hepatitis B Virus Infection and HBV Related Hepatocellular Carcinoma Progression, Therapeutic and Prognostic Potential. Infect Drug Resist. 2024;17:4477\u201386.","journal-title":"Infect Drug Resist"},{"key":"288_CR22","doi-asserted-by":"crossref","unstructured":"Riva G, et al. HPV Meets APOBEC: New Players in Head and Neck Cancer. Int J Mol Sci. 2021;22(3):1402.","DOI":"10.3390\/ijms22031402"},{"issue":"6","key":"288_CR23","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.celrep.2014.05.012","volume":"7","author":"S Henderson","year":"2014","unstructured":"Henderson S, et al. APOBEC-mediated Cytosine Deamination Links PIK3CA Helical Domain Mutations to Human Papillomavirus-driven Tumor Development. Cell Rep. 2014;7(6):1833\u201341.","journal-title":"Cell Rep"},{"issue":"12","key":"288_CR24","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.jmb.2017.04.021","volume":"429","author":"F Ito","year":"2017","unstructured":"Ito F, et al. Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination By Eleven Human APOBEC Proteins. J Mol Biol. 2017;429(12):1787\u201399.","journal-title":"J Mol Biol"},{"issue":"2","key":"288_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41379-020-0617-x","volume":"34","author":"PP Argyris","year":"2021","unstructured":"Argyris PP, et al. Endogenous APOBEC3B Overexpression Characterizes HPV-positive and HPV-negative Oral Epithelial Dysplasias and Head and Neck Cancers. Mod Pathol. 2021;34(2):280\u201390.","journal-title":"Mod Pathol"},{"issue":"10","key":"288_CR26","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/leu.2017.75","volume":"31","author":"Z Li","year":"2017","unstructured":"Li Z, et al. APOBEC Signature Mutation Generates an Oncogenic Enhancer That Drives LMO1 Expression in T-ALL. Leukemia. 2017;31(10):2057\u201364.","journal-title":"Leukemia"},{"key":"288_CR27","doi-asserted-by":"crossref","unstructured":"Hirose y, et al. Within-Host Variations of Human Papillomavirus Reveal APOBEC Signature Mutagenesis in the ViralGenome.\u300d Virol. 2018;92(12):e00017\u201318.","DOI":"10.1128\/JVI.00017-18"},{"issue":"8","key":"288_CR28","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.ccell.2023.06.010","volume":"41","author":"X Li","year":"2023","unstructured":"Li X, et al. Loss of SYNCRIP Unleashes APOBEC-driven Mutagenesis, Tumor Heterogeneity, and AR-targeted Therapy Resistance in Prostate Cancer. Cancer Cell. 2023;41(8):1427\u2013e144912.","journal-title":"Cancer Cell"},{"issue":"1","key":"288_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1158\/2326-6066.CIR-21-0146","volume":"10","author":"AV DiMarco","year":"2022","unstructured":"DiMarco AV, et al. APOBEC Mutagenesis Inhibits Breast Cancer Growth Through Induction of T Cell-Mediated Antitumor Immune Responses. Cancer Immunol Res. 2022;10(1):70\u201386.","journal-title":"Cancer Immunol Res"},{"issue":"7973","key":"288_CR30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41586-023-06303-1","volume":"620","author":"H Isozaki","year":"2023","unstructured":"Isozaki H, et al. Therapy-induced APOBEC3A Drives Evolution of Persistent Cancer Cells. Nature. 2023;620(7973):393\u2013401.","journal-title":"Nature"},{"issue":"9","key":"288_CR31","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.7150\/thno.73235","volume":"12","author":"R Shi","year":"2022","unstructured":"Shi R, et al. APOBEC-mediated Mutagenesis is a Favorable Predictor of Prognosis and Immunotherapy for Bladder Cancer Patients: Evidence From Pan-cancer Analysis and Multiple Databases. Theranostics. 2022;12(9):4181\u201399.","journal-title":"Theranostics"},{"issue":"1","key":"288_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.surg.2019.02.024","volume":"167","author":"NG Nicolson","year":"2020","unstructured":"Nicolson NG, et al. Immune Cell Infiltrate-associated Dysregulation of DNA Repair Machinery May Predispose to Papillary Thyroid Carcinogenesis. Surgery. 2020;167(1):66\u201372.","journal-title":"Surgery"},{"issue":"2","key":"288_CR33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1128\/MMBR.00040-08","volume":"73","author":"S Henriet","year":"2009","unstructured":"Henriet S, et al. Tumultuous Relationship Between the Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) and the Human APOBEC-3G and APOBEC-3F Restriction Factors. Microbiol Mol Biol Rev. 2009;73(2):211\u201332.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"11","key":"288_CR34","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nri1489","volume":"4","author":"RS Harris","year":"2004","unstructured":"Harris RS, Liddament MT. Retroviral Restriction By APOBEC Proteins. Nat Rev Immunol. 2004;4(11):868\u201377.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"288_CR35","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.annonc.2022.09.151","volume":"33","author":"P Selenica","year":"2022","unstructured":"Selenica P, et al. APOBEC Mutagenesis, Kataegis, Chromothripsis in EGFR-mutant Osimertinib-resistant Lung Adenocarcinomas. Ann Oncol. 2022;33(12):1284\u201395.","journal-title":"Ann Oncol"},{"issue":"4","key":"288_CR36","doi-asserted-by":"publisher","first-page":"383","DOI":"10.5582\/bst.2017.01103","volume":"11","author":"L Chen","year":"2017","unstructured":"Chen L, et al. APOBEC-mediated Genomic Alterations Link Immunity and Viral Infection During Human Papillomavirus-driven Cervical Carcinogenesis. Biosci Trends. 2017;11(4):383\u20138.","journal-title":"Biosci Trends"},{"issue":"8","key":"288_CR37","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.7150\/ijbs.83824","volume":"19","author":"J Yang","year":"2023","unstructured":"Yang J, et al. Comprehensive Analyses Reveal Effects On Tumor Immune Infiltration and Immunotherapy Response of APOBEC Mutagenesis and Its Molecular Mechanisms in Esophageal Squamous Cell Carcinoma. Int J Biol Sci. 2023;19(8):2551\u201371.","journal-title":"Int J Biol Sci"},{"key":"288_CR38","doi-asserted-by":"crossref","unstructured":"Faden DL, et al. APOBEC Mutagenesis Is Concordant between Tumor and Viral Genomes in HPv-Positive Head and Neck Squamous Cell Carcinoma. Viruses. 2021;13(8):1666.\u00a0","DOI":"10.3390\/v13081666"},{"issue":"45","key":"288_CR39","doi-asserted-by":"publisher","first-page":"22730","DOI":"10.1073\/pnas.1911385116","volume":"116","author":"L Zammataro","year":"2019","unstructured":"Zammataro L, et al. Whole-exome Sequencing of Cervical Carcinomas Identifies Activating ERBB2 and PIK3CA Mutations As Targets for Combination Therapy. Proc Natl Acad Sci U S A. 2019;116(45):22730\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"288_CR40","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.annonc.2021.02.006","volume":"32","author":"DJ McGrail","year":"2021","unstructured":"McGrail DJ, et al. High Tumor Mutation Burden Fails to Predict Immune Checkpoint Blockade Response Across All Cancer Types. Ann Oncol. 2021;32(5):661\u201372.","journal-title":"Ann Oncol"},{"issue":"3","key":"288_CR41","doi-asserted-by":"publisher","first-page":"790","DOI":"10.12998\/wjcc.v10.i3.790","volume":"10","author":"JP Song","year":"2022","unstructured":"Song JP, et al. High Tumor Mutation Burden Indicates a Poor Prognosis in Patients With Intrahepatic Cholangiocarcinoma. World J Clin Cases. 2022;10(3):790\u2013801.","journal-title":"World J Clin Cases"},{"issue":"1","key":"288_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/annonc\/mdy495","volume":"30","author":"TA Chan","year":"2019","unstructured":"Chan TA, et al. Development of Tumor Mutation Burden As an Immunotherapy Biomarker: Utility for the Oncology Clinic. Ann Oncol. 2019;30(1):44\u201356.","journal-title":"Ann Oncol"},{"issue":"1","key":"288_CR43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0021-9150(03)00133-3","volume":"169","author":"R Dutta","year":"2003","unstructured":"Dutta R, et al. Hepatic Gene Expression Profiling Reveals Perturbed Calcium Signaling in a Mouse Model Lacking Both LDL Receptor and Apobec1 Genes. Atherosclerosis. 2003;169(1):51\u201362.","journal-title":"Atherosclerosis"},{"issue":"1","key":"288_CR44","doi-asserted-by":"publisher","first-page":"7348","DOI":"10.1038\/s41467-021-26472-9","volume":"12","author":"JL Vos","year":"2021","unstructured":"Vos JL, et al. Neoadjuvant Immunotherapy With Nivolumab and Ipilimumab Induces Major Pathological Responses in Patients With Head and Neck Squamous Cell Carcinoma. Nat Commun. 2021;12(1):7348.","journal-title":"Nat Commun"},{"key":"288_CR45","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","volume":"27","author":"SY Lunt","year":"2011","unstructured":"Lunt SY, Vander MG, Heiden. Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation. Annu Rev Cell Dev Biol. 2011;27:441\u201364.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"9","key":"288_CR46","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41419-022-05213-w","volume":"13","author":"K Cai","year":"2022","unstructured":"Cai K, et al. FOXD1 Facilitates Pancreatic Cancer Cell Proliferation, Invasion, and Metastasis By Regulating GLUT1-mediated Aerobic Glycolysis. Cell Death Dis. 2022;13(9):765.","journal-title":"Cell Death Dis"},{"issue":"2","key":"288_CR47","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","volume":"40","author":"S Kumagai","year":"2022","unstructured":"Kumagai S, et al. Lactic Acid Promotes PD-1 Expression in Regulatory T Cells in Highly Glycolytic Tumor Microenvironments. Cancer Cell. 2022;40(2):201\u2013e2189.","journal-title":"Cancer Cell"},{"issue":"15","key":"288_CR48","doi-asserted-by":"publisher","first-page":"14667","DOI":"10.1021\/acsnano.3c02428","volume":"17","author":"J Yan","year":"2023","unstructured":"Yan J, et al. Metal-Phenolic Nanomedicines Regulate T-Cell Antitumor Function for Sono-Metabolic Cancer Therapy. ACS Nano. 2023;17(15):14667\u201377.","journal-title":"ACS Nano"},{"issue":"15","key":"288_CR49","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1158\/0008-5472.CAN-20-2562","volume":"81","author":"VK Gupta","year":"2021","unstructured":"Gupta VK, et al. Hypoxia-Driven Oncometabolite L-2HG Maintains Stemness-Differentiation Balance and Facilitates Immune Evasion in Pancreatic Cancer. Cancer Res. 2021;81(15):4001\u201313.","journal-title":"Cancer Res"},{"key":"288_CR50","doi-asserted-by":"publisher","first-page":"129945","DOI":"10.1016\/j.bmcl.2024.129945","volume":"112","author":"B Yang","year":"2024","unstructured":"Yang B, et al. Discovery of a Proteolysis Targeting Chimera (PROTAC) As a Potent Regulator of FOXP3. Bioorg Med Chem Lett. 2024;112:129945.","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Biological Procedures Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12575-025-00288-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12575-025-00288-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12575-025-00288-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:06:05Z","timestamp":1757307965000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologicalproceduresonline.biomedcentral.com\/articles\/10.1186\/s12575-025-00288-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["288"],"URL":"https:\/\/doi.org\/10.1186\/s12575-025-00288-z","relation":{},"ISSN":["1480-9222"],"issn-type":[{"value":"1480-9222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"2 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was reviewed and approved by Ethics Committee of the Tianjin Medical University Cancer Institute (Approval No. AE-2021021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"28"}}